LQT Therapeutics Announces Closing Of US$19M Series A Financing To Advance Lead Compound Through Phase 1 While Advancing Portfolio Assets

    Press/Media: Expert Comment

    Period10 Aug 2021

    Media coverage

    14

    Media coverage